NuVasive Products and the Globus Medical Merger: A Buyer's FAQ

Since I took over procurement for a 50-bed surgical center in 2020, I've managed roughly 200 purchase orders a year for spine-related supplies. I report to both operations and finance, so I'm the one who gets pulled into conversations that start with 'is this covered?' and end with 'can you find another vendor?' When the topic is NuVasive, the same questions come up again and again, especially after the Globus Medical NuVasive merger in 2023. This FAQ is for the buying side. I'm not a surgeon. I'm the person who signs the purchase orders.

One caveat: I've only worked at two facilities, a community hospital and an outpatient spine center. If you're at a large academic medical center, your contracting and support requirements will differ. What I have here is from real purchase orders, not a universal playbook.

Questions this FAQ covers

• What is NuVasive?
• What changed in the Globus Medical NuVasive merger in 2023?
• What NuVasive products should a buyer know?
• Is NuVasive related to nuclear medicine?
• Are NuVasive systems surgical energy devices?
• What is wound care in spine surgery?
• How should a buyer compare NuVasive bids?

What is NuVasive?

NuVasive designs surgical systems for minimally invasive spine surgery. If you hear a surgeon mention ALIF, TLIF, XLIF, or ACDF, NuVasive is often the company behind the implants and the access instruments. The product category is not one screw or one rod. It is a collection of implants, retractors, dilators, and monitoring tools used together. The Pulse surgical intelligence platform is part of that system, helping monitor nerve function during an operation.

From a purchasing perspective, you're buying into a system. The implant is only part of the cost. Training, support, and compatibility with the surgeon's preferred technique are part of the product. As of January 2025, NuVasive operates under the Globus Medical umbrella, but the product lines still carry the NuVasive name on many purchase orders.

What changed in the Globus Medical NuVasive merger in 2023?

Globus Medical completed its acquisition of NuVasive in 2023, and the combined company kept the Globus Medical name. According to Globus Medical's investor newsroom, the deal brought together NuVasive's spine access and intraoperative monitoring technology with Globus Medical's robotics and navigation offerings. For a buyer, that means one rep can now quote a more complete spine OR setup. That can simplify vendor consolidation. It can also complicate pricing because master agreements, contract terms, and service schedules get bundled together.

The most frustrating part is that old NuVasive pages still exist around the internet. I want to say we almost ordered a discontinued retractor kit in 2024 because an old spec sheet was still live. Now I ask for the current product line in writing and verify part numbers with the Globus Medical sales team before I issue a PO.

What NuVasive products should a buyer know?

Think in buckets, not part numbers. First, interbody fusion implants for ALIF, TLIF, XLIF, and ACDF. Second, minimally invasive access instruments, including retractors, dilators, and working channels that let the surgeon reach the spine without a large open incision. Third, the Pulse platform for neuromonitoring and integration. Fourth, biologics and bone graft material. There are more SKUs beneath those categories, but those four are the ones that show up in our requisitions.

The pricing trap is focusing on the implant bucket. Access instruments and monitoring are where the support burden lives. If a vendor quote is low on the implant but doesn't include loaner instruments or a clinical representative, the total cost can be higher than a quote with a higher unit price. I've learned to ask for service details before comparing line items.

Is NuVasive related to nuclear medicine?

No. NuVasive is a spinal surgery company. Nuclear medicine is a separate field that uses radioactive tracers for imaging and treatment. The only connection is in the spelling: both start with 'nu.' I think that is why a search for NuVasive sometimes pulls up nuclear medicine results. It is not a product category.

Why does that confusion matter? Because nuclear medicine equipment requires radiation shielding, radiopharmacy licensing, and regulatory oversight that has nothing to do with spinal implants. If a requisition for NuVasive arrives and suddenly mentions nuclear medicine, it is probably a routing error. I have stopped an order before because someone mixed up two categories in the system. The fix was easy once we changed the category instead of changing the product.

Are NuVasive systems surgical energy devices?

Not in the usual sense. A surgical energy device is an instrument that uses electricity, ultrasound, or radiofrequency to cut, coagulate, or seal tissue. Think electrosurgical pencils or vessel sealers. NuVasive's core product line is spinal implants and access systems. The Pulse platform does use electrical stimulation to monitor nerves, but that is monitoring, not tissue energy delivery.

Why does this distinction matter? Because regulatory and biomed requirements are different. Energy devices usually have a separate safety review process in hospitals. Spinal implant systems do not go through the same checklist. If you file a NuVasive system under 'surgical energy devices' in your purchasing system, it may get delayed. We lost a week once because a requisition was flagged for an energy device review it did not need.

What is wound care in spine surgery?

Wound care is the protocol for managing a surgical incision after the patient leaves the OR. It includes keeping the area clean and dry, changing dressings on the right schedule, and watching for signs of infection. The CDC surgical site infection guidelines describe the basics in one clear sentence: keep the wound covered, keep it clean, and know the signs that need a clinician.

NuVasive does not sell wound care dressings, as far as I know. But the surgical approach affects the wound. Minimally invasive systems are designed to create smaller access paths, which can reduce soft tissue disruption compared with larger open approaches. That may make wound care easier, but it is not a guarantee. When I evaluate NuVasive products, I ask about tissue displacement, not just implant specs, because the access system helps determine the incision we will be managing later.

How should a buyer compare NuVasive bids?

Compare total cost, not unit price. I still kick myself for a 2022 decision where I chose a lower implant quote to hit a budget target. The vendor did not include loaner instruments in the price. When we needed a replacement, we had to wait. Once we counted the OR delay and expedited shipping, the savings were gone.

Now I ask every vendor for four things in writing: a support schedule, a loaner instrument turnaround time, a training plan, and a named clinical specialist. If those are not in the quote, the quoted price is incomplete. In the last competitive bid I ran, the lowest option looked like it saved around $40,000 a year. My gut said the support was not there. I passed. Three months later, that vendor had a six-week backlog on a routine implant size. The numbers said one thing; the gut said another. Following the service details instead of the spreadsheet is part of why I still have this job.